LSL Pharma Group Inc. (TSXV:LSL)
Canada · Delayed Price · Currency is CAD 0.3150
+0.0150 (5.00%)
Oct 30, 2026, 3:59 PM EDT
LSL Pharma Group Market Cap
LSL Pharma Group has a market cap or net worth of CAD 39.92 million as of October 30, 2026. It is the 34,537th most valuable company in the world and the 1,038th biggest in Canada. Its market cap has decreased by 11.00% in one year.
Market Cap
39.92M
Enterprise Value
89.55M
Revenue
41.83M
Global Rank
Country Rank
#1,038 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since March 2, 2023, LSL Pharma Group's market cap has decreased from 61.67M to 39.92M, a decrease of -35.27%. That is a compound annual growth rate of -11.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 39.92M | -5.91% |
| Dec 31, 2025 | 42.43M | -10.43% |
| Dec 31, 2024 | 47.37M | 18.48% |
| Dec 29, 2023 | 39.98M | -35.17% |
| Mar 2, 2023 | 61.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Leef Brands | 61.11M |
| Vext Science | 60.69M |
| Medicure | 45.92M |
| Captiva Verde Wellness | 39.67M |
| BioNxt Solutions | 38.79M |
| Planet 13 Holdings | 38.56M |
| iAnthus Capital Holdings | 34.87M |
| ZYUS Life Sciences | 29.79M |